- Home
- WAVE vs PMCB Comparison
WAVE vs PMCB Comparison
Compare WAVE & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- PMCB
- Stock Information
- Founded
- WAVE 2011
- PMCB 1996
- Country
- WAVE Israel
- PMCB United States
- Employees
- WAVE N/A
- PMCB N/A
- Industry
- WAVE Electric Utilities: Central
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WAVE Utilities
- PMCB Health Care
- Exchange
- WAVE Nasdaq
- PMCB Nasdaq
- Market Cap
- WAVE 13.9M
- PMCB 15.8M
- IPO Year
- WAVE 2021
- PMCB N/A
- Fundamental
- Price
- WAVE $5.56
- PMCB $1.76
- Analyst Decision
- WAVE
- PMCB
- Analyst Count
- WAVE 0
- PMCB 0
- Target Price
- WAVE N/A
- PMCB N/A
- AVG Volume (30 Days)
- WAVE 27.6K
- PMCB 36.5K
- Earning Date
- WAVE 11-29-2024
- PMCB 09-17-2024
- Dividend Yield
- WAVE N/A
- PMCB N/A
- EPS Growth
- WAVE N/A
- PMCB N/A
- EPS
- WAVE N/A
- PMCB 0.54
- Revenue
- WAVE $306,000.00
- PMCB N/A
- Revenue This Year
- WAVE N/A
- PMCB N/A
- Revenue Next Year
- WAVE N/A
- PMCB N/A
- P/E Ratio
- WAVE N/A
- PMCB $3.31
- Revenue Growth
- WAVE 1076.92
- PMCB N/A
- 52 Week Low
- WAVE $1.01
- PMCB $1.39
- 52 Week High
- WAVE $6.60
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- WAVE 65.58
- PMCB 48.48
- Support Level
- WAVE $4.30
- PMCB $1.72
- Resistance Level
- WAVE $5.88
- PMCB $1.95
- Average True Range (ATR)
- WAVE 0.66
- PMCB 0.26
- MACD
- WAVE 0.16
- PMCB -0.01
- Stochastic Oscillator
- WAVE 68.08
- PMCB 38.75
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.